Revenue

A new report reveals the five structural forces, from AI to M&A, that are fundamentally rebuilding the financial services industry for 2026 and beyond.

Fast Company names CGS Immersive a top 10 innovator for its AI and XR tech that is transforming employee training with huge, measurable business results.

A new platform from cybersecurity veteran John Watters aims to revolutionize third-party risk with "compromise intelligence," detecting attacks on vendors early.

AIC unveils new platforms blending quantum-secure encryption and FIPS compliance to power next-gen AI surveillance and counter 'harvest now, decrypt later' attacks.

Electric cooking brand Current nabs a top spot on Fast Company's innovative list, signaling a major shift from flame to plug for backyard and balcony chefs.

The non-prime lender struck a deal with lenders to ensure liquidity, but it comes at a high price amid massive loan losses and scrutiny of its LendCare unit.

Modalic's autonomous swarm software gets 'awardable' status, signaling a major shift in how the Department of War rapidly acquires advanced AI.

Cipla Health launches a Masala Guava flavored ORS, targeting India's daily wellness market by turning a medical staple into an enjoyable hydration choice.

Amid declining 2025 revenue, Source Rock Royalties validates a new growth strategy with a profitable land sale, retaining future royalty rights.

Private equity firm Southfield Capital has acquired a majority stake in Metric Search, aiming to dominate the high-stakes recruitment market for niche talent.

Dr. Chidebelu Ufodike brings large-scale retail healthcare expertise to NJ Urology, signaling a strategic push for operational efficiency and expansion.

A groundbreaking study proves a botanical compound enhances protein absorption, leading to measurable gains in muscle strength and mass, especially for older adults.

Orex Minerals highlights spectacular drill results from Silver Viper's La Virginia project, validating its strategic shift from direct asset ownership to equity.

The CRDMO giant posted a 16.7% revenue jump in 2025, driven by a massive pipeline expansion and a strategic pivot to next-generation biologics.

RA Capital's major investment extends Karyopharm's runway, but future funding is now directly tied to the outcome of its pivotal endometrial cancer trial.

How AI platforms like Vic.ai are turning Accounts Payable from a cost center into a strategic lever for EBITDA growth and efficiency in PE portfolios.

Merck's breakthrough PAH drug is now covered in several provinces, offering new hope. But what about its high cost and access for the rest of Canada?

As AI agents become a new workforce, companies are scrambling to secure them. Andromeda's Galaxy release is the latest entry in a high-stakes race.

Forget perks and surveys. A new data-driven list ranks 1,750 employers on real-world pay and promotions, shifting power to job seekers.

Investors eye Cardinal Health's April 30 report for signs its aggressive diversification and specialty pharma push can sustain its powerful earnings momentum.